Cargando…
MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
BACKGROUND: Gastric cancer is the second most common cause of cancer death worldwide with poor overall prognosis. It is important to study the molecular mechanism of stomach adenocarcinoma (STAD). MAGED4B, a member of the melanoma antigen gene (MAGE) family, is highly expressed in many tumor cells a...
Autores principales: | Luo, Wen-Zhao, Li, Xian, Wu, Xiu-Xia, Shang, Yi-Wan, Meng, Dan-Hua, Chen, Yu-Long, Zhang, Qin-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171223/ https://www.ncbi.nlm.nih.gov/pubmed/37181643 http://dx.doi.org/10.2147/IJGM.S401507 |
Ejemplares similares
-
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
por: Zhang, Xiulei, et al.
Publicado: (2020) -
Influence of Prognostic Factors for Recurrence of Adenocarcinoma of the Stomach
por: Mehmedagic, Indira, et al.
Publicado: (2016) -
Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014) -
Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma
por: Wu, Ming, et al.
Publicado: (2020) -
Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma
por: Tang, Fenfen, et al.
Publicado: (2022)